Triple therapy reduces tumor burden and improves survival in glioblastoma models
A new research paper was published in Oncotarget, Volume 16, on March 27, 2025, titled "Imipridones ONC201/ONC206 + RT/TMZ triple (IRT) therapy ...
A new research paper was published in Oncotarget, Volume 16, on March 27, 2025, titled "Imipridones ONC201/ONC206 + RT/TMZ triple (IRT) therapy ...
A new review article highlights the transformative role of circular RNA (circRNA) in cancer, revealing its potential as both a ...
The critical role of EZH2, an essential epigenetic regulator, in cancer progression and treatment is underscored in this new review ...
Mayo Clinic announces the results of an innovative treatment approach that may offer improvement in overall survival in older patients with ...
Researchers are shining a light on cancer cells' energy centers – literally – to damage these power sources and trigger ...
Virtually every cell in the human body has an internal clock. These clocks take their cues from a central clock ...
The Wistar Institute's David B. Weiner, Ph.D. -; Executive Vice President, director of the Vaccine & Immunotherapy Center and W.W. Smith Charitable ...
Scientists have discovered a way to target elusive circular fragments of DNA that drive the survival of some of the ...
Glioblastoma is the most common and most aggressive primary brain tumor, with an average survival after diagnosis of less than ...
Glioblastoma is a particularly aggressive brain tumor that at present is incurable. Cancer doctors can extend patients' life expectancy through ...
Sepoy.net is a perfect place for people who want daily updates on news related to business, technology, entertainment, health, cryptocurrency etc.
Contact: hello@sepoy.net
© 2023 Sepoy.net